Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2011 Filed Feb 11, 2011 21:27 UTC |
Mikan George Lawrence IIIEVP UHG & CEO, Health Services
|
GrantCommon Stock | 53,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008861 · doc4.xml · nonDerivative · entry 2 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,419 F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:27 UTC |
Mikan George Lawrence IIIEVP UHG & CEO, Health Services
|
Tax withholdingCommon Stock | 2,478 | $42.07 | $104,249.46 |
DisclosureSEC source: 0001209191-11-008861 · doc4.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,936 Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:28 UTC |
MUNSELL WILLIAM AEVP, UnitedHealth Group
|
GrantCommon Stock | 53,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008863 · doc4.xml · nonDerivative · entry 2 MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,003 F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 53,483. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:28 UTC |
MUNSELL WILLIAM AEVP, UnitedHealth Group
|
Tax withholdingCommon Stock | 2,134 | $42.07 | $89,777.38 |
DisclosureSEC source: 0001209191-11-008863 · doc4.xml · nonDerivative · entry 1 MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,520 Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:29 UTC |
RENFRO LARRY CEVP, UnitedHealth Group
|
GrantCommon Stock | 59,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008868 · doc4.xml · nonDerivative · entry 3 RENFRO LARRY C · CIK 0001235046 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,848 F2 · shares: The restricted stock units will vest 100% on the fourth anniversary of the grant date. F3 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 53,483. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:29 UTC |
RENFRO LARRY CEVP, UnitedHealth Group
|
GrantCommon Stock | 53,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008868 · doc4.xml · nonDerivative · entry 2 RENFRO LARRY C · CIK 0001235046 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,423 F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:29 UTC |
RENFRO LARRY CEVP, UnitedHealth Group
|
Tax withholdingCommon Stock | 3,235 | $42.07 | $136,096.45 |
DisclosureSEC source: 0001209191-11-008868 · doc4.xml · nonDerivative · entry 1 RENFRO LARRY C · CIK 0001235046 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,940 Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:28 UTC |
RANGEN ERIC SSr VP & Chief Acctg Officer
|
GrantCommon Stock | 11,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008866 · doc4.xml · nonDerivative · entry 2 RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,523 F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 11,885. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:28 UTC |
RANGEN ERIC SSr VP & Chief Acctg Officer
|
Tax withholdingCommon Stock | 620 | $42.07 | $26,083.40 |
DisclosureSEC source: 0001209191-11-008866 · doc4.xml · nonDerivative · entry 1 RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,638 Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:29 UTC |
Sweere LoriEVP, Human Capital
|
GrantCommon Stock | 23,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008869 · doc4.xml · nonDerivative · entry 2 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,378 F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 23,770. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:29 UTC |
Sweere LoriEVP, Human Capital
|
Tax withholdingCommon Stock | 1,239 | $42.07 | $52,124.73 |
DisclosureSEC source: 0001209191-11-008869 · doc4.xml · nonDerivative · entry 1 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,608 Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:30 UTC |
Walsh Christopher JamesEVP and General Counsel
|
GrantCommon Stock | 23,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008872 · doc4.xml · nonDerivative · entry 2 Walsh Christopher James · CIK 0001475141 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,269 F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 23,770. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:30 UTC |
Walsh Christopher JamesEVP and General Counsel
|
Tax withholdingCommon Stock | 1,239 | $42.07 | $52,124.73 |
DisclosureSEC source: 0001209191-11-008872 · doc4.xml · nonDerivative · entry 1 Walsh Christopher James · CIK 0001475141 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,499 Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:30 UTC |
Tuckson Reed VaughnEVP & Chief of Medical Affairs
|
GrantCommon Stock | 23,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008871 · doc4.xml · nonDerivative · entry 2 Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,946 F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 23,770. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:30 UTC |
Tuckson Reed VaughnEVP & Chief of Medical Affairs
|
Tax withholdingCommon Stock | 2,134 | $42.07 | $89,777.38 |
DisclosureSEC source: 0001209191-11-008871 · doc4.xml · nonDerivative · entry 1 Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,176 Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:31 UTC |
WELTERS ANTHONYEVP, UnitedHealth Group
|
GrantCommon Stock | 53,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008874 · doc4.xml · nonDerivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,512 F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 53,483. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:31 UTC |
WELTERS ANTHONYEVP, UnitedHealth Group
|
Tax withholdingCommon Stock | 2,100 | $42.07 | $88,347.00 |
DisclosureSEC source: 0001209191-11-008874 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,029 Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:32 UTC |
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
|
GrantCommon Stock | 59,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008875 · doc4.xml · nonDerivative · entry 3 WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,615 F2 · shares: The restricted stock units will vest 100% on the fourth anniversary of the grant date. F3 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 53,483. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:32 UTC |
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
|
GrantCommon Stock | 53,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008875 · doc4.xml · nonDerivative · entry 2 WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,190 F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:32 UTC |
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
|
Tax withholdingCommon Stock | 2,478 | $42.07 | $104,249.46 |
DisclosureSEC source: 0001209191-11-008875 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,707 Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:32 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
GrantCommon Stock | 23,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008876 · doc4.xml · nonDerivative · entry 2 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,306 F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 23,770. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:32 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
Tax withholdingCommon Stock | 1,239 | $42.07 | $52,124.73 |
DisclosureSEC source: 0001209191-11-008876 · doc4.xml · nonDerivative · entry 1 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,536 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 22:09 UTC |
LAWSON RODGER ADirector
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008512 · doc4.xml · nonDerivative · entry 1 LAWSON RODGER A · CIK 0001187442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 F1 · kind: Represents deferred stock units granted to Mr. Lawson in connection with his appointment to the Board of Directors of UnitedHealth Group Incorporated. The deferred stock units will vest at a rate of 25% annually on February 8 from the years 2012 through 2015, subject to continued service as a director on the applicable vesting date. The deferred stock units must be retained by the director until departure from the Board. Read SEC document |
| February 03, 2011 Filed Feb 4, 2011 23:52 UTC |
BOUDREAUX GAILEVP & Pres, UnitedHealthcare
|
Tax withholdingCommon Stock | 3,168 | $43.04 | $136,350.72 |
DisclosureSEC source: 0001209191-11-007315 · doc4.xml · nonDerivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · EVP & Pres, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,756 F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| February 03, 2011 Filed Feb 4, 2011 23:53 UTC |
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
|
Tax withholdingCommon Stock | 4,508 | $43.04 | $194,024.32 |
DisclosureSEC source: 0001209191-11-007316 · doc4.xml · nonDerivative · entry 1 HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,533,881 Read SEC document |
| February 03, 2011 Filed Feb 4, 2011 23:53 UTC |
Mikan George Lawrence IIIEVP and CFO
|
Tax withholdingCommon Stock | 3,168 | $43.04 | $136,350.72 |
DisclosureSEC source: 0001209191-11-007317 · doc4.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,414 F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| February 03, 2011 Filed Feb 4, 2011 23:53 UTC |
MUNSELL WILLIAM AEVP & Pres Enterprise Svcs Grp
|
Tax withholdingCommon Stock | 3,005 | $43.04 | $129,335.20 |
DisclosureSEC source: 0001209191-11-007318 · doc4.xml · nonDerivative · entry 1 MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,654 Read SEC document |
| February 03, 2011 Filed Feb 4, 2011 23:54 UTC |
RANGEN ERIC SSr VP & Chief Acctg Officer
|
Tax withholdingCommon Stock | 845 | $43.04 | $36,368.80 |
DisclosureSEC source: 0001209191-11-007319 · doc4.xml · nonDerivative · entry 1 RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,258 F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. F2 · balance_after: Since the date of the reporting person's last ownership report, he has agreed to transfer (i) 6,650 shares of common stock, (ii) 3,684 shares of restricted stock, (iii) restricted stock units and stock settled stock appreciation rights that convert into 63,414 shares of common stock (which include shares acquired on February 3, 2011 upon the vesting of a portion of his restricted stock unit award) and (iv) performance based restricted stock units that may convert into 1,574 shares of common stock to his ex-wife pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-wife. Read SEC document |
| February 03, 2011 Filed Feb 4, 2011 23:54 UTC |
RENFRO LARRY CEVP & CEO Public Sr Mkts Grp
|
Tax withholdingCommon Stock | 9,079 | $43.04 | $390,760.16 |
DisclosureSEC source: 0001209191-11-007320 · doc4.xml · nonDerivative · entry 1 RENFRO LARRY C · CIK 0001235046 · EVP & CEO Public Sr Mkts Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,175 Read SEC document |
| February 03, 2011 Filed Feb 4, 2011 23:55 UTC |
Sweere LoriEVP, Human Capital
|
Tax withholdingCommon Stock | 1,573 | $43.04 | $67,701.92 |
DisclosureSEC source: 0001209191-11-007321 · doc4.xml · nonDerivative · entry 1 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,847 Read SEC document |
| February 03, 2011 Filed Feb 4, 2011 23:55 UTC |
Tuckson Reed VaughnEVP & Chief of Medical Affairs
|
Tax withholdingCommon Stock | 2,783 | $43.04 | $119,780.32 |
DisclosureSEC source: 0001209191-11-007323 · doc4.xml · nonDerivative · entry 1 Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,310 Read SEC document |
| February 03, 2011 Filed Feb 4, 2011 23:56 UTC |
Walsh Christopher JamesEVP and General Counsel
|
Tax withholdingCommon Stock | 2,359 | $43.04 | $101,531.36 |
DisclosureSEC source: 0001209191-11-007324 · doc4.xml · nonDerivative · entry 1 Walsh Christopher James · CIK 0001475141 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,738 Read SEC document |
| February 03, 2011 Filed Feb 4, 2011 23:56 UTC |
WELTERS ANTHONYEVP & Pres Public & Sr Mkt Grp
|
Tax withholdingCommon Stock | 2,738 | $43.04 | $117,843.52 |
DisclosureSEC source: 0001209191-11-007325 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Public & Sr Mkt Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,129 Read SEC document |
| February 03, 2011 Filed Feb 4, 2011 23:57 UTC |
WICHMANN DAVID SEVP & Pres, UHG Operations
|
Tax withholdingCommon Stock | 3,168 | $43.04 | $136,350.72 |
DisclosureSEC source: 0001209191-11-007326 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · EVP & Pres, UHG Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,185 Read SEC document |
| February 03, 2011 Filed Feb 4, 2011 23:57 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
Tax withholdingCommon Stock | 2,359 | $43.04 | $101,531.36 |
DisclosureSEC source: 0001209191-11-007327 · doc4.xml · nonDerivative · entry 2 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,775 Read SEC document |
| February 03, 2011 Filed Feb 4, 2011 23:57 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
SaleCommon Stock | 3,102 | $44.00 | $136,488.00 |
DisclosureSEC source: 0001209191-11-007327 · doc4.xml · nonDerivative · entry 1 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,134 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2010. Read SEC document |
| January 27, 2011 Filed Jan 28, 2011 22:32 UTC |
Sweere LoriEVP, Human Capital
|
SaleCommon Stock | 2,950 | $40.78 | $120,301.00 |
DisclosureSEC source: 0001209191-11-005605 · doc4.xml · nonDerivative · entry 4 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,420 F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| January 26, 2011 Filed Jan 27, 2011 22:02 UTC |
Walsh Christopher JamesEVP and General Counsel
|
SaleCommon Stock | 1,741 | $40.47 | $70,458.27 |
DisclosureSEC source: 0001209191-11-005298 · doc4.xml · nonDerivative · entry 3 Walsh Christopher James · CIK 0001475141 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,097 Read SEC document |
| January 26, 2011 Filed Jan 27, 2011 22:02 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
SaleCommon Stock | 1,290 | $40.31 | $52,001.71 |
DisclosureSEC source: 0001209191-11-005299 · doc4.xml · nonDerivative · entry 3 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,236 F1 · price: This transaction was executed in multiple trades ranging from $40.31 to $40.312 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| January 26, 2011 Filed Jan 27, 2011 22:03 UTC |
Shine Kenneth IrwinDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,167 | $0.00 Strike: $20.68 | $0.00 |
DisclosureSEC source: 0001209191-11-005301 · doc4.xml · derivative · entry 3 Shine Kenneth Irwin · CIK 0001455025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,167 shares Expires 2019-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2011 Filed Jan 27, 2011 22:03 UTC |
Shine Kenneth IrwinDirector
|
SaleCommon Stock | 3,167 | $40.59 | $128,548.53 |
DisclosureSEC source: 0001209191-11-005301 · doc4.xml · nonDerivative · entry 2 Shine Kenneth Irwin · CIK 0001455025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,477 Read SEC document |
| January 26, 2011 Filed Jan 27, 2011 22:03 UTC |
Shine Kenneth IrwinDirector
|
Exercise / conversionCommon Stock | 3,167 | $20.68 | $65,493.56 |
DisclosureSEC source: 0001209191-11-005301 · doc4.xml · nonDerivative · entry 1 Shine Kenneth Irwin · CIK 0001455025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2011 Filed Jan 28, 2011 22:32 UTC |
Sweere LoriEVP, Human Capital
|
Exercise / conversionStock Appreciation Right · Derivative | 14,141 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0001209191-11-005605 · doc4.xml · derivative · entry 6 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,420 Underlying: Common Stock · 14,141 shares Expires 2019-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Read SEC document |
| January 26, 2011 Filed Jan 28, 2011 22:32 UTC |
Sweere LoriEVP, Human Capital
|
Exercise / conversionStock Appreciation Right · Derivative | 5,000 | $0.00 Strike: $33.94 | $0.00 |
DisclosureSEC source: 0001209191-11-005605 · doc4.xml · derivative · entry 5 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,821 Underlying: Common Stock · 5,000 shares Expires 2018-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on June 5 from the years 2009 through 2012. Read SEC document |
| January 26, 2011 Filed Jan 28, 2011 22:32 UTC |
Sweere LoriEVP, Human Capital
|
Tax withholdingCommon Stock | 16,191 | $40.25 | $651,687.75 |
DisclosureSEC source: 0001209191-11-005605 · doc4.xml · nonDerivative · entry 3 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,370 F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| January 26, 2011 Filed Jan 28, 2011 22:32 UTC |
Sweere LoriEVP, Human Capital
|
Exercise / conversionCommon Stock | 14,141 | $29.74 | $420,553.34 |
DisclosureSEC source: 0001209191-11-005605 · doc4.xml · nonDerivative · entry 2 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,561 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| January 26, 2011 Filed Jan 28, 2011 22:32 UTC |
Sweere LoriEVP, Human Capital
|
Exercise / conversionCommon Stock | 5,000 | $33.94 | $169,700.00 |
DisclosureSEC source: 0001209191-11-005605 · doc4.xml · nonDerivative · entry 1 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 22:02 UTC |
Walsh Christopher JamesEVP and General Counsel
|
Exercise / conversionStock Appreciation Right · Derivative | 10,000 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0001209191-11-005298 · doc4.xml · derivative · entry 4 Walsh Christopher James · CIK 0001475141 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,842 Underlying: Common Stock · 10,000 shares Expires 2019-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 22:02 UTC |
Walsh Christopher JamesEVP and General Counsel
|
Tax withholdingCommon Stock | 8,259 | $40.62 | $335,480.58 |
DisclosureSEC source: 0001209191-11-005298 · doc4.xml · nonDerivative · entry 2 Walsh Christopher James · CIK 0001475141 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,838 Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 22:02 UTC |
Walsh Christopher JamesEVP and General Counsel
|
Exercise / conversionCommon Stock | 10,000 | $29.74 | $297,400.00 |
DisclosureSEC source: 0001209191-11-005298 · doc4.xml · nonDerivative · entry 1 Walsh Christopher James · CIK 0001475141 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.